To this end, we hypothesized that prostate cancer cells exploit FA pathway-mediated DNA repair to survive the DNA-damaging effects of chemotherapy and that FANCI plays a central role in this through its ability to regulate the accumulation of other FA core complex members to the damage site. The gene discussed is FANCI; the disease is Familial prostate cancer.